United Bank (Virginia)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,908
| Closed | -$322K | – | 132 |
|
|
2026
Q1 | $322K | Hold |
1,908
| – | – | 0.04% | 110 |
|
|
2025
Q4 | $322K | Hold |
1,908
| – | – | 0.04% | 111 |
|
|
2025
Q3 | $275K | Hold |
1,908
| – | – | 0.03% | 112 |
|
|
2025
Q2 | $241K | Hold |
1,908
| – | – | 0.03% | 124 |
|
|
2025
Q1 | $244K | Hold |
1,908
| – | – | 0.03% | 127 |
|
|
2024
Q4 | $252K | Hold |
1,908
| – | – | 0.03% | 117 |
|
|
2024
Q3 | $278K | Hold |
1,908
| – | – | 0.03% | 119 |
|
|
2024
Q2 | $262K | Sell |
1,908
-300
| -14% | -$40K | 0.03% | 121 |
|
|
2024
Q1 | $303K | Hold |
2,208
| – | – | 0.04% | 113 |
|
|
2023
Q4 | $300K | Hold |
2,208
| – | – | 0.04% | 117 |
|
|
2023
Q3 | $270K | Hold |
2,208
| – | – | 0.04% | 120 |
|
|
2023
Q2 | $280K | Hold |
2,208
| – | – | 0.03% | 123 |
|
|
2023
Q1 | $285K | Hold |
2,208
| – | – | 0.04% | 129 |
|
|
2022
Q4 | $290K | Hold |
2,208
| – | – | 0.04% | 121 |
|
|
2022
Q3 | $258K | Hold |
2,208
| – | – | 0.04% | 133 |
|
|
2022
Q2 | $260K | Hold |
2,208
| – | – | 0.04% | 129 |
|
|
2022
Q1 | $288K | Hold |
2,208
| – | – | 0.04% | 135 |
|
|
2021
Q4 | $337K | Hold |
2,208
| – | – | 0.04% | 136 |
|
|
2021
Q3 | $357K | Hold |
2,208
| – | – | 0.05% | 125 |
|
|
2021
Q2 | $361K | Hold |
2,208
| – | – | 0.05% | 123 |
|
|
2021
Q1 | $332K | Hold |
2,208
| – | – | 0.05% | 132 |
|
|
2020
Q4 | $334K | Sell |
2,208
-227
| -9% | -$32.4K | 0.05% | 134 |
|
|
2020
Q3 | $330K | Sell |
2,435
-817
| -25% | -$111K | 0.06% | 111 |
|
|
2020
Q2 | $445K | Buy |
3,252
+121
| +4% | +$15.4K | 0.08% | 95 |
|
|
2020
Q1 | $337K | Sell |
3,131
-10
| -0.3% | -$1.15K | 0.07% | 100 |
|
|
2019
Q4 | $379K | Hold |
3,141
| – | – | 0.07% | 106 |
|
|
2019
Q3 | $313K | Hold |
3,141
| – | – | 0.06% | 117 |
|
|
2019
Q2 | $343K | Hold |
3,141
| – | – | 0.06% | 114 |
|
|
2019
Q1 | $351K | Hold |
3,141
| – | – | 0.06% | 105 |
|
|
2018
Q4 | $303K | Hold |
3,141
| – | – | 0.06% | 122 |
|
|
2018
Q3 | $383K | Hold |
3,141
| – | – | 0.08% | 95 |
|
|
2018
Q2 | $345K | Sell |
3,141
-147
| -4% | -$15.7K | 0.08% | 96 |
|
|
2018
Q1 | $351K | Hold |
3,288
| – | – | 0.08% | 97 |
|
|
2017
Q4 | $351K | Buy |
+3,288
| New | +$351K | 0.09% | 107 |
|
Other funds holding IBB
CB
United Bank (Virginia)'s IBB Position: Q2 2026 in Review
United Bank (Virginia) sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 1,908 shares — an estimated $322K sold.
United Bank (Virginia) first reported a position in IBB in Q4 2017 and held it in 34 quarters. The position peaked at $445K in Q2 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- United Bank (Virginia) reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
- United Bank (Virginia) sold 1,908 iShares Biotechnology ETF shares in Q2 2026, an estimated $322K.
- United Bank (Virginia) first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 34 quarters.
- United Bank (Virginia)'s iShares Biotechnology ETF position peaked at $445K in Q2 2020.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on United Bank (Virginia)'s 13F filing for Q2 2026, filed 30 Jul 2026.